Cytochrome p450 part 3: drug interactions: essential concepts and considerations.
暂无分享,去创建一个
[1] Janet K. Williams,et al. Implications for educating the next generation of nurses on genetics and genomics in the 21st century. , 2011, Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing.
[2] N. Bojanić,et al. [Drug interactions with grapefruit]. , 2010, Medicinski pregled.
[3] L. Becquemont,et al. Pharmacogenomics of adverse drug reactions: practical applications and perspectives. , 2009, Pharmacogenomics.
[4] W. Aronow,et al. Updates on Cytochrome P450-Mediated Cardiovascular Drug Interactions , 2009, American journal of therapeutics.
[5] R. Hazin,et al. Rhabdomyolysis induced by simvastatin-fluconazole combination. , 2008, Journal of the National Medical Association.
[6] S. Z. Imam,et al. Medicinal importance of grapefruit juice and its interaction with various drugs , 2007, Nutrition journal.
[7] T. Lynch,et al. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. , 2007, American family physician.
[8] I. Zadezensky,et al. Grapefruit‐Drug Interactions: Can Interactions With Drugs Be Avoided? , 2006, Journal of clinical pharmacology.
[9] P. Thompson,et al. Statin-associated myopathy. , 2003, JAMA.
[10] James P. Wilson,et al. FDA Adverse Event Reports on Statin-Associated Rhabdomyolysis , 2002, The Annals of pharmacotherapy.
[11] James P. Wilson,et al. Rhabdomyolysis and HMG-CoA Reductase Inhibitors , 2001, The Annals of pharmacotherapy.
[12] T. Ohta,et al. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[13] C. Gregg. Drug interactions and anti-infective therapies. , 1999, The American journal of medicine.
[14] C. Ioannides. Cytochromes P450 : role in the metabolism and toxicity of drugs and other xenobiotics , 2008 .
[15] M. Matsumoto,et al. Undesirable Effects of Citrus Juice on the Pharmacokinetics of Drugs , 2005, Drug safety.
[16] J. Feely,et al. Pharmacokinetic-Pharmacodynamic Drug Interactions with HMG-CoA Reductase Inhibitors , 2002, Clinical pharmacokinetics.